Johnson & Johnson CEDEAR (JNJ)
BCBA
Closed
Oct 7, 2026
Day's Range
27,680.0052 wk Range
17,010.00Overview - JNJ - Johnson & Johnson CEDEAR
Key Statistics
Valuation
Enterprise Value
1,589,458.72T
P/E (Trailing)
‪11.00‬
PEG Ratio
‪-96.23‬
Price / Sales (TTM)
‪3,590.39‬
Price / Book
‪8.13‬
EV / EBITDA
‪30,098.44‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Shares Outstanding
2.40B
Float
35.91B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.05%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪28,041.20‬
200-Day Avg
‪24,496.80‬
Dividends
Payout Ratio
‪20.26%‬
Frequency
Quarterly
Market Cap - JNJ - Johnson & Johnson CEDEAR
Peers - JNJ - Johnson & Johnson CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- JNJBCBAJohnson & Johnson CEDEAR353.29TMarket Cap+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,257.20TMarket Cap+29.46%52-week change57.14P/E (Trailing)‪33.46%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR159.66TMarket Cap+22.83%52-week change16.85P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR103.32TMarket Cap+22.93%52-week change6.68P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt75.56TMarket Cap+22.40%52-week change8.00P/E (Trailing)‪9.80%‬Profit Margin
- GILDBCBAGilead Sciences Inc.75.38TMarket Cap+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.69.12TMarket Cap+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - JNJ - Johnson & Johnson CEDEAR
About
Johnson & Johnson CEDEAR is an Argentine depositary receipt that represents an economic interest in Johnson & Johnson’s ordinary shares, allowing local investors to access the company’s global healthcare exposure in pesos through Argentina’s capital market. Each receipt represents a fractional interest designed to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
